Retatrutide 20mg (R&D Only)
$198.00
A 20mg Retatrutide formulation supplied in a pre-filled research device, provided exclusively for controlled laboratory R&D applications. Delivered in sealed format to support compound stability analysis, formulation studies, and delivery mechanism evaluation.
Produced for laboratory research only. Not for human or veterinary consumption.
Each Retatrutide 20mg Research kit includes:
Pre-filled Research pen (20mg Retatrutide)
Research information sheet
Storage:
Store refrigerated (2–8°C). Do not freeze.
Supplied in fixed-volume sealed format for laboratory analysis.
Delivery: Dispatched with a cold pack.
Retatrutide 20mg
The Retatrutide 20mg peptide represents a breakthrough in metabolic and endocrine research compounds. this high-purity formulation is ideal for investigators exploring the mechanisms of weight regulation, glucose homeostasis, energy expenditure, and insulin sensitivity. Retatrutide is unique in its class: a triple-receptor agonist that simultaneously targets the GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon (GCGR) receptors.
Manufactured under GMP-style protocols and supplied as a lyophilized (freeze-dried) powder, Retatrutide 20mg ensures consistent and reproducible dosing for research environments. The compound supports detailed exploration of metabolic pathways including appetite suppression, fat oxidation, basal metabolic rate modulation, and receptor signalling dynamics.
Alluvi Health Care Review
-
Triple-Agonist Mechanism: Activates GLP-1R, GIPR, and GCGR receptors—offering a broader modulatory effect compared with traditional single-agonist peptides.
-
High-Purity Grade: Verified ≥99% purity via HPLC and MS testing, with full Certificate of Analysis (COA) available.
-
Extended Format – 20 mg Vial: Optimised for long-term protocols, dose escalation studies, and sustained metabolic research models. Advanced Manufacturing: Produced in GMP-compliant facilities, ensuring traceability, batch consistency, and research-grade reliability.
Alluvi Retatrutide 20Mg
Store the lyophilised vial at 2–8 °C, protected from light and moisture. Use sterile reconstitution procedures in line with laboratory SOPs. After reconstitution, the solution should be refrigerated and used in compliance with the institution’s research protocols.
With its sophisticated triple-agonist profile and research-grade purity, Retatrutide 20mg is poised at the forefront of peptide-based metabolic research. Whether your study focuses on obesity, type 2 diabetes, insulin resistance, or energy-balance modelling, this peptide offers a powerful and reliable platform for cutting-edge investigations.
Related products
